LEGN - Legend Biotech Corporation So'nggi... | Finranks

12.08.2026

Legend's Pipeline Is Starting To Matter

Legend Biotech is transitioning from a capital-intensive biotech to a profitable, CARVYKTI-driven commercial cell therapy company. Q2 results highlight 52% YoY revenue growth, strong international CARVYKTI momentum, and a swing to $57.7M operating income, signaling sustainable profitability. CARVYKTI's 50% YoY sales growth is driven by earlier-line adoption and global expansion, with over 70% use now in 2L–4L settings.

11.08.2026

Legend Biotech Corporation (LEGN) Q2 2026 Earnings Call Transcript

11.08.2026

Legend Biotech Gains 6% on Q2 Earnings Beat as Adjusted EPS Doubles Consensus

Shares of Legend Biotech (NASDAQ:LEGN | LEGN Price Prediction) are climbing 6% to $21.88 Tuesday midday after the company reported Q2 2026 results that paired a solid revenue beat with the first quarter of company-wide profitability in its history.

11.08.2026

Legend Biotech Q2 Earnings Call Highlights

Legend Biotech NASDAQ: LEGN reported second-quarter 2026 results marked by continued global growth for CARVYKTI and the company's first quarter of company-wide profitability on both an IFRS and adjusted basis, management said during its earnings call.

04.08.2026

Top 3 Health Care Stocks You'll Regret Missing This Quarter

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Videolar

No Data

There is no data to display

Reytinglar oshishi / pasayishi

Ticker	Tashkilot	Reyting o‘zgarishi	Maqsadli narx	Sana
LEGN	Oppenheimer	Perform	undefined >> undefined	August 12th 2026

Legend Biotech Corporation (LEGN)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Legend Biotech Corporation (LEGN)

Legend's Pipeline Is Starting To Matter

Legend Biotech Corporation (LEGN) Q2 2026 Earnings Call Transcript

Legend Biotech Gains 6% on Q2 Earnings Beat as Adjusted EPS Doubles Consensus

Legend Biotech Q2 Earnings Call Highlights

Top 3 Health Care Stocks You'll Regret Missing This Quarter

Videolar

No Data

Reytinglar oshishi / pasayishi

Search stocks

Legend Biotech Corporation (LEGN)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Legend Biotech Corporation (LEGN)

Legend's Pipeline Is Starting To Matter

Legend Biotech Corporation (LEGN) Q2 2026 Earnings Call Transcript

Legend Biotech Gains 6% on Q2 Earnings Beat as Adjusted EPS Doubles Consensus

Legend Biotech Q2 Earnings Call Highlights

Top 3 Health Care Stocks You'll Regret Missing This Quarter

Videolar

No Data

Reytinglar oshishi / pasayishi